Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

PURPOSE: The therapeutic efficacy of targeted therapy for adenosquamous carcinoma (ASC) of the lung remains unclear and the role of epidermal growth factor receptor (EGFR) testing in patients with ASC also remains controversial. We aimed to analyze the efficacy of EGFR tyrosine kinase inhibitors (EG...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Onco Targets Ther
Auteurs principaux: Fan, Liwen, Yang, Haitang, Yao, Feng, Zhao, Yang, Gu, Haiyong, Han, Ke, Zhao, Heng
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5229167/
https://ncbi.nlm.nih.gov/pubmed/28123305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114451
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires